Roivant Sciences Ltd. (NASDAQ:ROIV) set out its long-term vision on Tuesday during its Investor Day, outlining accelerated timelines and expanded commercial ambitions across several late-stage programs. Chief executive Matt Gline said the company is entering a pivotal period anchored by…
Trading in Warner Bros. Discovery, Inc. (NASDAQ:WBD) is quiet on Thursday. But that hasn't been the case lately. The shares have soared amid a bidding war for the company. • Warner Bros. Discovery stock is trading at elevated levels. What should…
Nvidia Corp (NASDAQ:NVDA) attracted renewed attention from Wall Street after fresh insights from a recent investor meeting highlighted its continued lead in artificial intelligence computing and strong multi-year demand visibility. BofA Securities analyst Vivek Arya maintained a Buy rating on…
Nvidia Corp (NASDAQ:NVDA) attracted renewed attention from Wall Street after fresh insights from a recent investor meeting highlighted its continued lead in artificial intelligence computing and strong multi-year demand visibility. BofA Securities analyst Vivek Arya maintained a Buy rating on…
The Dow Jones Industrial Average pushed to fresh record highs Thursday as investors rotated out of expensive tech stocks and into industrials, financials and healthcare. Broader risk appetite stayed firm after the Federal Reserve delivered its third straight interest-rate cut…
Nike, Inc. (NYSE:NKE) stock rose Thursday as investors grew more optimistic about the company’s product pipeline and strengthening demand signals across key channels. The sportswear giant is also leaning into a broader consumer base, including value-focused shoppers on Amazon, as…
PayPal Holdings, Inc. (NASDAQ:PYPL) shares were steady Thursday as investors weighed ongoing softness in consumer spending across the platform. The company continues to grapple with sluggish momentum in its core checkout business, raising fresh questions about the pace of its…
On Tuesday, Elanco Animal Health Incorporated (NYSE:ELAN) used its first Investor Day in five years to signal a turning point for the company, outlining a more focused strategy aimed at sustainable growth, margin expansion, and a stronger balance sheet. CEO…
Natera Inc. (NASDAQ:NTRA) on Wednesday revealed initial translational research results from the international randomized Phase 3 PALLAS study. Data were presented at the San Antonio Breast Cancer Symposium (SABCS). These first data, generated from a U.S. biomarker cohort of 420…
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock is higher on Thursday, after the company shared preliminary results from its exploratory Phase 2 trial of setmelanotide in patients with Prader-Willi syndrome (PWS). PWS is a rare genetic disorder characterized by muscle weakness and…